JAZZ vs POST · P/E 1988, rev $4.07B vs P/E 15, rev $8.16B
Jazz Pharmaceuticals PLC (JAZZ) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the JAZZ and POST stock pages for the full models.
Not investment advice.